Tackling Cardiovascular Risk: New Evidence from Personalized Medicine

Author(s): Rosa Finelli, Antonietta V. Pascale, Paola Marotta, Anna Guida, Michele Ciccarelli*

Journal Name: Current Pharmacogenomics and Personalized Medicine
Formerly Current Pharmacogenomics

Volume 15 , Issue 1 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies.

Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care.

Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.

Keywords: Cardiovascular diseases, genomics, metabolomics, innovation and communication technology, personalized medicine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [60 - 66]
Pages: 7
DOI: 10.2174/1875692115666170508152128
Price: $25

Article Metrics

PDF: 31